A detailed history of Knott David M Jr transactions in Evolus, Inc. stock. As of the latest transaction made, Knott David M Jr holds 108,682 shares of EOLS stock, worth $1.73 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
108,682
Previous 80,000 35.85%
Holding current value
$1.73 Million
Previous $1.12 Million 5.27%
% of portfolio
0.47%
Previous 0.4%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$10.45 - $13.76 $1.14 Million - $1.5 Million
108,682 New
108,682 $1.18 Million
Q1 2024

May 14, 2024

BUY
$9.99 - $14.91 $69,270 - $103,385
6,934 Added 9.49%
80,000 $1.12 Million
Q4 2023

Feb 13, 2024

BUY
$7.6 - $10.53 $555,301 - $769,384
73,066 New
73,066 $769,000
Q3 2023

Nov 13, 2023

BUY
$7.15 - $10.2 $486,671 - $694,273
68,066 New
68,066 $622,000
Q2 2023

Aug 11, 2023

BUY
$7.23 - $10.52 $148,215 - $215,660
20,500 New
20,500 $149,000
Q1 2023

May 11, 2023

BUY
$7.81 - $11.05 $817,831 - $1.16 Million
104,716 New
104,716 $886,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $895M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.